TrialBMC cancer2009

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.

Rohini Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.